
HRSA audits go virtual for COVID-19: What covered entities need to know
/ by Ivy Espendez, Director, 340B Compliance and Audits
In response to the COVID-19 pandemic, HRSA’s Office of Pharmacy Affairs has made a number of adjustments to its guidelines for the 340B drug pricing program for stakeholders.